The One Big Beautiful Bill Act (OBBA), enacted on July 4, 2025, is significantly impacting the U.S. healthcare sector by enhancing tax benefits related to Health Savings Accounts (HSAs) and expanding employer-sponsored insurance offerings. This legislation is expected to drive increased consumer healthcare spending, benefiting managed care organizations (MCOs) and pharmacy benefit managers (PBMs) as companies upgrade their benefits packages.
The OBBA’s provisions, including the expansion of HSA eligibility and increased dependent care FSA limits, are creating a favorable environment for companies like UnitedHealth Group, Humana, and CVS Health. For instance, UnitedHealth’s integrated platform positions it well to capture growth from HSA-compatible plans, while Humana’s Medicare Advantage payment rate increase provides a substantial boost to its core business. CVS Health’s Caremark segment is also seeing revenue growth linked to the expanding enrollment in HSA-compatible plans.
As the OBBA reshapes healthcare spending dynamics, investors should focus on companies with diversified revenue streams across insurance and pharmacy benefits, as they are likely to capitalize on the rising demand for commercial healthcare solutions.
Source: marketbeat.com